Coronavirus: Contagion now threatens the health of Indian economy
Overdependence on Chinese market further slows down the
economy, hits travel, auto and pharma industries; stokes fears of the global
recession
If further
proof was ever needed that the world indeed is a small place, this is it. The
impact of the coronavirus (COVID-19) outbreak in China’s Wuhan city is such
that the world is now on notice. This is a contagion in ways more than one.
The
reasons are not difficult to fathom. China, the factory to the world, accounts
for 16 per cent of the global GDP and most high-impact economies depend on it
for supplies. China has doubled the trade with the rest of the world than it
had in 2003 when the SARS epidemic hit the region.
Though one
has to acknowledge the COVID-19 impact far outstrips that of previous
outbreaks, be it SARS in China, Hong Kong, and Canada in 2003, MERS in South
Korea in 2015, or for that matter the Avian Flu in the US way in 1957, the lack
of preparedness across nations is surprising.
Clearly it
is regions with fungible borders like Europe that have been the hardest hit
apart from establishments and businesses with highly mobile workforces, like in
the Indian tech industry.
“From an
economic perspective, what started as a temporary regional shock now seems at
risk of transforming into a more protracted global phenomenon—with possible
effects on public confidence and supply chains well beyond the worst affected
areas,” Goldman Sachs analysts said in a note on the impact of COVID-19 last
week.
Recession
ahead?
Getting
into the New Year, the global economy seemed to be primed to emerge from the
sluggish phase it faced through 2019, thanks to trade wars and geopolitical
tensions, not to speak of the uncertainties in the run-up to the US elections
later this year. But, coronavirus and the mood over the past one week have
clearly revived fears of a recession.
The same
Goldman Sachs’ analysts quoted above dubbed COVID-19 as 2020’s Black Swan
moment and predicted a contraction in global economic growth at 5 per cent and
2 per cent in Q1 and Q2 of 2020 respectively. Though they stopped short of
predicting a recession, this is in sharp contrast to the confidence shown by
them late last year of a revival in global growth at 3.4 per cent in 2020.
Multilateral
bodies are more direct in predicting dire times ahead.
The
Organisation of Economic Cooperation and Development (OECD) estimated a sharp
slowdown in the world economy in the first half of 2020, dragging the full-year
growth to 1.5 per cent, half of what it had projected before the virus
outbreak. The intensity of the impact would be felt more by northern advanced
economies hit by confidence, travel and spending.
The United
Nations Conference on Trade and Development (UNCTAD) on Wednesday (March 4)
said global trade had taken a $50 billion-plus hit in February alone on account
of the factory shutdowns there. India, with a $348 million hit on its trade,
would be among the top 15 countries to be negatively impacted by COVID-19.
Further,
worries of a global recession strengthened on Tuesday (March 3) when the US
Federal Reserve, in a surprise move, executed a half a percentage point cut in
interest rates to put more money into the US economy and encourage spending.
This was the first time since the financial crisis of 2008 that the US Fed
resorted to such an emergency cut. But fears continue to stalk the markets.
Travel
bans
The first
and most visible casualty of COVID-19 has been the global travel and tourism
sector with most regions of China going into lockdown while many nations
curtailed contacts with affected countries. A spate of meeting cancellations
have also plagued the global MICE industry.
The global
airline industry had been under pressure through 2019. COVID-19 turned the
screws deeper. The first to bite the dust was UK’s Flybe, a struggling airline
that was talking to the UK government for a bailout package since January. The
regional airline announced on Thursday it would go into liquidation.
This
prompted the International Air Transport Authority (IATA) to warn that airlines
stand to lose $113 billion in sales if COVID-19 continues to spread around the
world. The commercial airlines industry revenues in 2019 were pegged at $838
billion. Just two weeks ago, IATA had said that lost sales would be in the
range of $30 billion. In comparison, the SARS outbreak in 2002-2003 had
resulted in a 45 per cent drop in passenger demand and a revenue hit of $10
billion to the industry.
Over 70
international airlines cancelled all their flights to and from China on news of
the virus while immigration and quarantine restrictions in over 60 countries
took their toll on the industry. It may
not be long before other weak airlines, including in India, spiral to the
bottom. Shipping lines are going through similar rough waters with global
freight and container traffic taking a hit.
Skidding
wheels
China is
the world’s biggest carmaker and market accounting for 23 per cent of global
sales. Wuhan in Hubei Province, the epicentre of the coronavirus outbreak, is
known as the car city, thanks to its huge factories. It is also the biggest
supplier of car components to factories across the world. Chinese car sales in
February plummeted 92 per cent after the coronavirus outbreak.
Hyundai
and Kia reportedly had to stop production lines in Korea while Nissan said it
would stop production at its Japanese lines. Likewise, automakers in other
regions said production would be curtailed. Indian automakers import 10-30 per
cent of components from China. As a result, ratings agency Fitch Solutions said
it expected Indian auto production to contract by 8.3 per cent in 2020 on
account of COVID-19. Just about revering from a bad 2019, when growth
contracted 13.2 per cent, the sector will be under tremendous pressure.
Pill
chill
China also
accounts for a majority of the global drug ingredients supplies to most major
medicines manufacturers across the world including Indian drug makers. So much
so that Indian import of Active Pharmaceutical Ingredients (APIs) that go into
the manufacture of many critical antibiotics have been on a steady rise over
the years and today account for almost 70-85 per cent in consumption value.
This makes
India highly vulnerable to price fluctuations and increases the risk from the
shutdown of Chinese outfits. Bulk drugs and drug intermediaries from China in
fact account for almost 3 per cent of India’s total imports. It is no surprise
then that Chinese suppliers jacked up their prices within days of COVID-19,
making Indian importers pay almost twice the price earlier. What is more
worrisome is the fear of stocks running out by end of this month with many of
the supplier units, particularly in Hubei, not expected to open till mid-April.
Apex
industry body the Confederation of Indian Industries (CII), flagged India’s
high dependence on Chinese APIs. There is a need to de-risk and set up or
utilise existing API manufacturing units within India for a larger share of the
API supplies, it said in a note to the government of India late last month in
the wake of the COVID-19.
Tech
blowout
The
COVID-19 impact on the tech sector has been the most pronounced. Apple Inc. was the first to flag the downside
saying it was not expecting to meet its second-quarter financial guidance due
to the outbreak. Apart from sourcing most of the components for iPhones and
other products from there, Apple also generates 15 per cent of its sales from
China. Microsoft and Nvidia followed
suit, adding that they too expected to miss guidance this quarter.
Where the
Indian electronics sector is concerned, a similar story is playing out as in
bulk drugs.
Some
component importers across the board said they expect five-week delays in
supplies reaching from Chinese factories. India has emerged the second-largest
mobile phone manufacturer after China, value addition is still minimal and most
components are still sourced from outside. Likewise, supplies of printer parts
to PC components and printed circuit boards are at risk if factories in China
do not open soon. India imported electrical and electronic equipment worth
US$23.24 billion in 2018 from China.
The
silver lining
The pall
of gloom notwithstanding, there is a silver lining. Every economic incident has
led to innovations and rear-guard action against disruptions. For instance, the
2003 SARS crisis saw the emergence of e-commerce in a big way paving the way
for the success of the likes of Alibaba. Now with nearly 300 million students
out of school due to COVID-19, perhaps a beneficiary from the current episode
could be the e-learning industry. And then companies will be forced to reassess
their global supply chain strategies to reduce overdependence on Chinese
companies and revisit their management practices as in the case of the Indian
pharma sector and electronics components manufacture.
Clearly
this is too good a crisis to waste. Not to learn from it would be unpardonable.
(The
writer is a Hyderabad-based journalist and has covered business and technology
trends for the last three decades)
Post a Comment